Hemofilia II. Aspectos moleculares y de genética poblacional Hemophilia II. Molecular and population genetics

Hemofilia II. Aspectos moleculares y de genética poblacional Hemophilia II. Molecular and population genetics

La prevalencia de la hemofilia esporádica fue estimada hace más de 40 años y se demostró que aproximadamente un tercio de los casos son de novo. La mayoría de las mutaciones que ocurren en la hemofilia se producen durante la espermatogénesis masculina; en otros casos, los cambios ocurren en los esta...

Full description

Bibliographic Details
Main Author:	Dunia Castillo-González
Format:	Article
Language:	Spanish
Published:	Editorial Ciencias Médicas 2012-06-01
Series:	Revista Cubana de Hematología, Inmunología y Hemoterapia
Subjects:	Hemofilia capacidad reproductiva mutaciones factor VIII factor IX Hemophilia reproductive capacity mutations
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000200002

Similar Items

Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica
by: Lizbeth Salazar-Sánchez, et al.
Published: (2004-09-01)

Importancia del diagnóstico de portadoras en familias con antecedentes de hemofilia
by: Kalia Lavaut Sánchez

“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India
by: Sangita Darshan Shah, et al.
Published: (2019-01-01)

Clinical profile and demographic characteristics of moderate and severe hemophilia patients in a tertiary care hospital of Bangladesh
by: Mohammed Nadimul Islam, et al.
Published: (2022-07-01)

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
by: Tine M.H.J. Goedhart, et al.
Published: (2022-01-01)

Hemofilia: aspectos históricos y genéticos Hemophilia: historical and genetic aspects
by: Dunia Castillo-González
Published: (2012-03-01)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
by: Jacky K. Yu, et al.
Published: (2019-07-01)

Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors
by: Anshu Shrestha, et al.
Published: (2021-01-01)

Tratamiento de la infección en la hepatitis C y la hemofilia Hepatitis C related with hemophilia. Treatment of infection
by: René A Rivero Jiménez
Published: (2009-04-01)

Perioperative Management of Patients with Hemophilia during Spinal Surgery
by: Kazuyoshi Kobayashi, et al.
Published: (2018-06-01)

GENÉTICA MOLECULAR DE LA HEMOFILIA A EN UNA FAMILIA COLOMBIANA CON DIAGNÓSTICO DE ENFERMEDAD DE VON WILLEBRAND Y DE HEMOFILIA A
by: Diana Carolina Polanía Villanueva, et al.
Published: (2014-12-01)

The odds and implications of coinheritance of hemophilia A and B
by: Corinne Karch, et al.
Published: (2020-07-01)

Impact of novel hemophilia therapies around the world
by: Margareth C. Ozelo, et al.
Published: (2022-03-01)

Desenvolvimento de inibidores do fator VIII na hemofilia A Development of factor VIII inhibitors in hemophilia A
by: Daniel G. Chaves, et al.
Published: (2009-01-01)

Purificación del factor IX recombinante expresado en leche de cerdas transgénicas Purification of recombinant factor IX expressed in milk of transgenic sows
by: Armando Cádiz Lahens, et al.
Published: (2006-08-01)

Hemofilia adquirida
by: Martín Milanesio, et al.
Published: (2022-03-01)

Hemofilia A adquirida
by: Ana Luísa Albuquerque, et al.
Published: (2022-06-01)

Molecular study in children with hemophilia A in Colombia: analysis of Intron 1 and 22 inversion using long-distance PCR technique
by: María Fernanda Garcés, et al.
Published: (2017-04-01)

Augmented Degradation of Factors VIII and IX in the Intermittent Movement State
by: Haim Cohen, et al.
Published: (2023-06-01)

"Relation of Factor VIII and IX Inhibitors with ABO Blood Groups in 150 Patients with Haemophilia A and B "
by: Hassan Mansouri Torghabeh, et al.
Published: (2006-03-01)

Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus
by: John Puetz
Published: (2023-11-01)

Strategies for Hemophilia Treatment, a literature review of current evidence
by: Fahimeh Ghasemi, et al.
Published: (2023-12-01)

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
by: Cecilia Augustsson, et al.
Published: (2020-10-01)

Hemofilia A adquirida associada à artrite reumatoide Acquired hemophilia associated with rheumatoid arthritis
by: Marlene Freire, et al.
Published: (2009-06-01)

Clinical and Laboratory Approaches to Hemophilia A
by: Hassan Mansouritorghabeh
Published: (2015-05-01)

Sensibilidad del tiempo parcial de tromboplastina activado a la deficiencia de factores VIII y IX Y a la heparina Sensitivity of the activated partial thromboplastin time to the deficiency of factors VIII and IX and heparin
by: Alina Díaz Concepción, et al.
Published: (2001-04-01)

MYOCARDIAL INFARCTION AND HEMOPHILIA
by: A. S. Galyavich, et al.
Published: (2016-03-01)

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
by: Byung Suk Moon, et al.
Published: (2013-07-01)

Immunogenicity of Current and New Therapies for Hemophilia A
by: Alessandra N. L. Prezotti, et al.
Published: (2022-07-01)

New developments in the management of moderate-to-severe hemophilia B
by: Nazeef M, et al.
Published: (2016-04-01)

Educational needs of hematologists and laboratory professionals regarding factor activity assays
by: Adcock DM, et al.
Published: (2018-04-01)

European principles of inhibitor management in patients with haemophilia
by: P. L. F. Giangrande, et al.
Published: (2018-04-01)

European principles of inhibitor management in patients with haemophilia: implications of new treatment options
by: C. Hermans, et al.
Published: (2020-08-01)

Recombinant porcine factor VIII corrects thrombin generation in vitro in plasma from patients with congenital hemophilia A and inhibitors
by: Claude Négrier, et al.
Published: (2022-05-01)

Systematic molecular analysis of hemophilia A patients from Colombia
by: Luz Karime Yunis, et al.
Published: (2018-11-01)

Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies
by: Pratima Chowdary, et al.
Published: (2022-07-01)

Potential role of a new PEGylated recombinant factor VIII for hemophilia A
by: Wynn TT, et al.
Published: (2016-06-01)

Colecistectomía laparoscópica y papiloplastia transcística en paciente hemofílico severo
by: Elizabeth Sosa, et al.
Published: (2018-09-01)

Anesthesia Concerns and Management in Case of Severe Hemophilia A: A Case Report and Review of Literature
by: Deepali Jamgade, et al.
Published: (2022-01-01)

A case of subdural hematoma with a medical history of hemophilia a and a review of related literature
by: Yi Zhao, et al.
Published: (2018-05-01)